Crinecerfont Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Crinecerfont Capsule (capsule) from Neurocrine Biosciences, Inc. with status To Be Discontinued. The shortage was first posted on 04/28/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Neurocrine Biosciences, Inc.
- Package NDC
- 70370-5025-1
- Dosage Form
- Capsule
- Presentation
- Crenessity, Capsule, 25 mg (NDC 70370-5025-1)
- Initial Posting
- 04/28/2026
- Revised Date